Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119266347 | 11926634 | 7 | F | 2015 | 20160915 | 20160119 | 20160919 | EXP | PHHY2015CA106368 | NOVARTIS | 55.80 | YR | F | Y | 0.00000 | 20160919 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119266347 | 11926634 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | U | 21008 | 30 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119266347 | 11926634 | 1 | Neuroendocrine tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119266347 | 11926634 | DE |
| 119266347 | 11926634 | OT |
| 119266347 | 11926634 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119266347 | 11926634 | Abdominal distension | |
| 119266347 | 11926634 | Asthenia | |
| 119266347 | 11926634 | Blood pressure increased | |
| 119266347 | 11926634 | Blood pressure systolic increased | |
| 119266347 | 11926634 | Death | |
| 119266347 | 11926634 | Dehydration | |
| 119266347 | 11926634 | Diarrhoea | |
| 119266347 | 11926634 | Fatigue | |
| 119266347 | 11926634 | Flushing | |
| 119266347 | 11926634 | Heart rate decreased | |
| 119266347 | 11926634 | Hot flush | |
| 119266347 | 11926634 | Hyperhidrosis | |
| 119266347 | 11926634 | Hypocalcaemia | |
| 119266347 | 11926634 | Hyponatraemia | |
| 119266347 | 11926634 | Intestinal obstruction | |
| 119266347 | 11926634 | Local swelling | |
| 119266347 | 11926634 | Lung disorder | |
| 119266347 | 11926634 | Muscle atrophy | |
| 119266347 | 11926634 | Nausea | |
| 119266347 | 11926634 | Peripheral swelling | |
| 119266347 | 11926634 | Pruritus | |
| 119266347 | 11926634 | Rash generalised | |
| 119266347 | 11926634 | Vomiting | |
| 119266347 | 11926634 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119266347 | 11926634 | 1 | 20150808 | 0 |